South Korea’s Celltrion Inc on Thursday said British regulators had given it regulatory approval for a phase I clinical trial of its experimental COVID-19 treatment drug.
The company will enrol participants for a clinical study in the UK after approval from the Medicines and Healthcare Products Regulatory Agency (MHRA), Celltrion said in a statement.
South Korean regulators on July 17 approved an early stage clinical trial for the drug, making it the country’s first such antibody drug to be tested on humans.
HELP US SPREAD GOOD NEWS!
I run this site in my spare time and thoroughly enjoy giving you all positive news! If you've enjoyed the site we'd love for you to help me share the good news far and wide, share us on Reddit, your Facebook or your Twitter and spread a little positivity around.
Who Am I ?
Just someone trying to highlight the positive news amongst a sea of negativity.